The results of the TROPOS (Treatment of Peripheral Osteoporosis) study, published today in the Journal of Clinical Endocrinology and Metabolism show that strontium ranelate (Protelos®) significantly reduces the risk of all non vertebral and, in a high risk group, hip fractures over three years.